CLINICAL_TRIALS
trial_result
· 2026-04-14
Clinical Trial Update: A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum [Phase 3]
Summary
A Phase 3 clinical trial to evaluate spesolimab in people with Pyoderma Gangrenosum is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Pyoderma Gangrenosum | Phase 3 | Status: RECRUITING